In vitro kinetics of insulin release by microencapsulated rat islets: effect of the size of the microcapsules
Tóm tắt
Microencapsulation has been proposed to protect islets of Langerhans against immune rejection in xenogenic transplantation. However, to achieve glucose homeostasis in human diabetic patients, insulin release by microencapsulated islets must increase in response to a glucose load. We microencapsulated isolated rat islets using the alginate-polylysine procedure. Capsule size was found to range from 300 to 800 μm, and microencapsulated islets were separated according to their size. Groups of 10 microencapsulated islets, either small (350 μm) or large (650 μm) were placed in plastic microwells, in minimal Eagle's culture medium containing either 5.5 mol/l glucose (basal) or 16.5 mol/l glucose and 5.5 mol/l theophylline (stimulatory medium). The increase in insulin concentration in the surrounding medium was then serially determined over 30 min: (1) With the small capsules, insulin concentration rose from 199 ±20 to 297 ±58 μU/ml in basal medium, and from 236 ±23 to 510 ±121 μU/ml in stimulatory medium (n = 10 preparations), the difference between the data obtained with the basal or the stimulatory medium being significant (p<0.01) from the 5th min onwards. (2) With large capsules, insulin concentration increased from 182±9 to 266±44 μU/ml, and from 216 ±19 to 297 ±34 μU/ml in basal and stimulatory medium, respectively, with no apparent significant difference. The magnitude of insulin secretion in response to glucose by unencapsulated islets was, under similar conditions, seven-fold greater. We conclude therefore that the size of the microcapsules is an essential parameter which has to be considered for the optimisation of the microencapsulation procedure.
Tài liệu tham khảo
Lim F, Sun A (1980) Microencapsulated islets as bioartificial endocrine pancreas. Science 210: 908–910
Leung YF, O'Shea GM, Goosen MFA, Sun AM (1983) Microencapsulation of crystalline insulin or islets of Langerhans: an insulin diffusion study. Artif Organs 7: 208–212
O'Shea GM, Goosen MFA, Sun AM (1984) Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim Biophys Acta 804: 133–136
Sun AM, O'Shea GM, Gharapetian H (1985) Artificial cells containing islets as bioartificial pancreas. In: Nosé Y, Kjellstrand C, Ivanovich P (eds) Progress in artificial organs. ISAO Press, Cleveland, pp 601–606
O'Shea GM, Sun AM (1986) Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice. Diabetes 35: 943–946
Ricker AT, Stockberger SM, Halban PA, Eisenbarth GS, Bonner-Weir S (1986) Hyperimmune response to microencapsulated xenogenic tissue in non-obese diabetic mice. In: Jaworski MA, Molnar GD, Rajotte RV, Singh B (eds) The immunology of diabetes mellitus. Elsevier, Amsterdam, pp 193–200
Darquy S, Reach G (1985) Immunoisolation of pancreatic B cells by microencapsulation: an in vitro study. Diabetologia 28: 776–780
Sorensen J, Colton CK, Hillman RS, Soeldner JS (1982) Use of a physiological pharmacokinetic model of glucose homeostasis for assessment of performance requirements for improved insulin therapy. Diabetes Care 5: 148–156
Lacy P, Kostianovsky M (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35–39
Helman A, Gilbert M, Pfister-Lemaire N, Reach G, Assan R (1984) Glucagon and insulin secretion and their biological activities in hypothermic rats. Endocrinology 115: 1722–1728
Morgan CR, Lazarow A (1963) Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 12: 115–126
Snedecor GW, Cochran WG (1967) Statistical methods, 6th edn. Iowa State University Press, Ames, Iowa
Creque HM, Langer R, Folkman J (1980) One month of sustained release from a polymer implant. Diabetes 29: 37–40
Brown L, Munoz C, Siemer L, Edelman E, Langer R (1986) Controlled release of insulin from polymer matrices. Control of diabetes in rats. Diabetes 35: 692–697
Wang PY (1987) Prolonged release of insulin by cholesterol-matrix implant. Diabetes 36: 1068–1072
Theodorou N, Howell SL (1979) An assessment of diffusion chambers for use in pancreatic islet cell transplantation. Transplantation 27: 350–353
Koncz L, Davidoff F, DeLellis RA, Selby M, Zimmermann CE (1976) Quantitative aspects of the metabolite response to pancreatic islet transplantation in rats with severe ketotic diabetes. Metabolism 25: 147–156
Hommel M, Sun AM, Goosen MFA (1984) Droplet generation. Canadian Patent 458605